Advisors Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-582
Closed -$65K 1861
2016
Q1
$65K Sell
582
-414
-42% -$43K ﹤0.01% 1567
2015
Q4
$108K Sell
996
-844
-46% -$96.6K ﹤0.01% 1535
2015
Q3
$184K Sell
1,840
-1,336
-42% -$145K ﹤0.01% 1394
2015
Q2
$362K Sell
3,176
-1,279
-29% -$155K 0.01% 1226
2015
Q1
$466K Sell
4,455
-6,594
-60% -$703K 0.01% 1124
2014
Q4
$1.33M Sell
11,049
-8,220
-43% -$1.08M 0.02% 766
2014
Q3
$2.82M Sell
19,269
-10,935
-36% -$1.69M 0.04% 488
2014
Q2
$5.05M Sell
30,204
-211
-0.7% -$37.5K 0.07% 337
2014
Q1
$6.04M Buy
30,415
+4,894
+19% +$924K 0.09% 278
2013
Q4
$4.87M Buy
25,521
+11,122
+77% +$2.07M 0.08% 317
2013
Q3
$2.44M Buy
14,399
+4,745
+49% +$737K 0.04% 445
2013
Q2
$1.46M Buy
+9,654
New +$1.37M 0.03% 538

Other funds holding CLB

Advisors Asset Management's CLB Position: Q2 2016 in Review

Advisors Asset Management sold out of Core Laboratories (CLB) in Q2 2016, closing a stake of 582 shares — an estimated $65K sold.

Advisors Asset Management first reported a position in CLB in Q2 2013 and held it in 12 quarters. The position peaked at $6.04M in Q1 2014. 383 funds tracked by Wall St. Rank hold CLB as of Q2 2016.

  • Advisors Asset Management reported no remaining Core Laboratories position as of Q2 2016 after selling out during the quarter.
  • Advisors Asset Management sold 582 Core Laboratories shares in Q2 2016, an estimated $65K.
  • Advisors Asset Management first reported a position in Core Laboratories in Q2 2013 and held it in 12 quarters.
  • Advisors Asset Management's Core Laboratories position peaked at $6.04M in Q1 2014.
  • 383 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2016.

Based on Advisors Asset Management's 13F filing for Q2 2016, filed 8 Aug 2016.